C.H. Robinson Worldwide, Inc. (CHRW)

NASDAQ: CHRW · USD

$127

-16.38 (-11.4%)· Recorded snapshot

StockMarketAgent Research · Analyzed 2026-10-12

Our latest published analysis: CHRW rated Sell

C.H. Robinson Worldwide, Inc.'s published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.

Fair value

$102 / share

Potential value

$126 / share

Upside to FV

-26.4%

from $127

Moat

6.5/10

Narrow

Read full analysis →View archive · 24mo

9-phase methodology · same model in each published edition

Market cap	$16.2B
Revenue (ttm)	18.2B
Net income (ttm)	668.8M
EPS (ttm)	$5.57
Shares out	115.5M
P/E (trailing)	22.9x
P/E (forward)	21.5x
Dividend	$2.52 (1.98%)
Volume	4,394,956
Beta	0.95

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 18.2B
Net income (ttm): 668.8M
EPS (ttm): $5.57
P/E (trailing): 22.9x
P/E (forward): 21.5x
Market cap: $16.2B

Item	P1	P2	P3	P4	P5	Trend
Period	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31	Trend
Revenue	$23.10B	$24.70B	$17.60B	$17.72B	$16.23B	-8.4%
Gross profit	$1.61B	$1.87B	$1.14B	$1.31B	$1.36B	-4.1%
Operating income	$1.08B	$1.27B	$514.6M	$669.1M	$795.0M	-7.4%
Net income	$844.2M	$940.5M	$325.1M	$465.7M	$587.1M	-8.7%
EPS (diluted)	$6.31	$7.40	$2.72	$3.86	$4.83	-6.5%
EBITDA	$1.17B	$1.36B	$613.6M	$766.3M	$888.4M	-6.7%
R&D	$20.2M	$25.5M	$33.6M	$44.3M	—	+29.9%
SG&A	$526.4M	$603.4M	$651.7M	$639.6M	$564.3M	+1.8%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ABBV	AbbVie Inc.	505.6B	80.8x	7.9x	17.7%	+3.7%	+29.1%	Sell
ABT	Abbott Laboratories	177.6B	38.2x	3.7x	7.2%	+2.7%	-17.2%	Reduce
ACN	Accenture plc	144.3B	18.0x	2.0x	27.9%	+8.0%	+0.4%	Hold
AAL	American Airlines Group Inc.	8.3B	—	0.1x	3.0%	+20.0%	-6.9%	Hold
ADP	Automatic Data Processing, Inc.	113B	25.3x	5.1x	62.8%	+7.7%	+4.5%	Hold
ALLE	Allegion plc	15.2B	22.5x	3.5x	19.4%	+8.8%	+7.2%	Hold

Base and Bull scenarios

Base55%

Price target

$102.26

-26.4% from spot

The Base scenario represents the modal expected trajectory, generating our mid-case intrinsic fair value of $102.26. Here, freight demand remains subdued through late FY2026 before recovering gradually. Lean AI efficiencies permanently reduce administrative overhead, but carrier linehaul inflation prevents gross margin expansion beyond baseline operating margins. At $138.97, the stock trades at an unwarranted premium to intrinsic value, offering an expected return of -26.4%.

Consolidated revenue reaches $18,375.49M in FY2026 (+13.2%) and $19,606.65M in FY2027 (+6.7%).
Operating margin reaches 5.35% in FY2026, 5.45% in FY2027, and stabilizes at 5.50% across FY2028-FY2030.
Diluted EPS expands to $6.28 in FY2026 and $7.48 in FY2027.
Net reinvestment rate tracks 10.0% of NOPAT in FY2026 and 12.0% thereafter.
Weighted average cost of capital is 8.705% with cost of equity at 9.200%.
Terminal P/E multiple is 17.0x with long-term growth of 2.5%.

Bull20%

Price target

$126.36

-9.1% from spot

Under the Bull scenario, North American freight demand stages a sharp recovery as industrial inventory restocking rebounds. Shippers accept substantial contractual rate increases, eliminating the margin squeeze and allowing CHRW to capture peak transactional brokerage spreads. Operating leverage from Lean AI agents expands operating margins well beyond historical mid-cycle targets, while normalized working capital restores strong cash conversion.

Freight demand stages an accelerated cyclical inflection, driving robust consolidated revenue acceleration across FY2026 and FY2027.
Contractual rate increases successfully catch up with carrier linehaul costs, driving substantial NAST gross profit margin expansion.
Lean AI multi-agent workflows maintain headcount discipline, driving consolidated operating margin toward cycle-peak levels by FY2028.
Working capital requirements normalize as freight rates stabilize, lifting free cash flow conversion toward historical peak levels.

Sensitivity: Ke × terminal growth

The highlighted cell is Fair value when every assumption sits at its base level ($102.26). Each row and column shows what Fair value becomes when one assumption moves.

Ke ↓ / g →	2.0%	2.3%	2.5%	2.8%	3.0%
8.2%	$109	$111	$113	$116	$119
8.7%	$104	$106	$107	$109	$112
9.2%	$99.3	$101	$102	$104	$106
9.7%	$95.2	$96.4	$97.7	$99.1	$101
10.2%	$91.6	$92.6	$93.7	$94.9	$96.2

Scorecard

Published factor rows and weighted composite

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E21.5

P25 n/aP50 n/aP75 n/a

Trailing P/E27.2

P25 n/aP50 n/aP75 n/a

ROE38.9

P25 n/aP50 n/aP75 n/a

ROIC21.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CHRW indicators

Market & fundamental data

Available fields

290

Groups with data

Currency

USD

Showing 290 of 290 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001043277
Company name	C.H. Robinson Worldwide, Inc.
Country	United States
Country code	US
CUSIP number	12541W209
Earnings date	2026-10-28
Earnings time	bmo
Employees	11,599
Employees change	-1,567
Employees growth	-11.9%
Enterprise value	$16.6B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-09
Fiscal year end	December
Founded	1905
In index	SP500
Industry	Integrated Freight & Logistics
IPO date	1997-10-15
Is primary listing	Yes
Is SPAC	No
ISIN number	US12541W2098
Last 10-K release date	2026-02-13
Last earnings date	2026-10-28
Last refreshed	2026-10-28
Last stock split date	2005-10-17
Last stock split type	Forward
Market cap	$14.7B
Market cap category	Large-Cap
Next earnings date	2027-01-27
Options	Yes
Price	$127.21
Price currency	USD
Sector	Industrials
SIC code	4731
Stock price date	2026-10-28
Symbol	CHRW
U.S. state	Minnesota
Website	https://www.chrobinson.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	21.24x
Average P/E ratio (10Y)	22.29x
Average P/E ratio (3Y)	29.34x
Average P/E ratio (5Y)	23.9x
Earnings yield	4.38%
EV/Earnings	24.75x
EV/EBIT	17.95x
EV/EBITDA	17.25x
EV/FCF	31.84x
EV/Sales	0.91x
FCF / EV yield	3.14%
FCF yield	3.56%
Forward EV/Sales	0.86x
Forward P/E	17.47x
Forward P/S	0.76x
Graham number	41.02805
Graham upside	-67.54%
Industry forward P/E	15.85x
Industry P/E	20.89x
Lynch fair value	$27.83
Lynch upside	-77.98%
P/(FCF - SBC) ratio	34.6x
P/(OCF - SBC) ratio	33.47x
P/B ratio	10.68x
P/E ratio	22.86x
P/FCF ratio	28.07x
P/OCF ratio	27.33x
P/S ratio	0.8x
PEG ratio	1.02x
Price/EBITDA ratio	15.21x
Sector forward P/E	26.24x
Sector P/E	40.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	5.06%
EBITDA margin	5.27%
Effective tax rate	18.55%
FCF margin	2.85%
Gross margin	8.26%
Operating margin	5.06%
Pretax margin	4.51%
Profit margin	3.67%
Profit per employee	$57,661
Profitable quarters	114
Profitable years	31
Revenue per employee	$1.6M
ROA	9.92%
ROA (5Y)	9.66%
ROCE	27.9%
ROE	38.92%
ROE (5Y)	37.01%
ROIC	21.5%
ROIC (5Y)	21%
SBC / revenue	0.54%
Tax / revenue	0.84%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	12.79%
EPS growth (Q)	24.63%
EPS growth (QoQ)	7.05%
EPS growth 10Y	4.42%
EPS growth 3Y	19.35%
EPS growth 5Y	-0.29%
EPS growth quarters	2
EPS growth years	2
FCF growth	-39.4%
FCF growth (Q)	-55.29%
FCF growth (QoQ)	289.66%
FCF growth 3Y	-28.48%
FCF growth 5Y	28.38%
Gross profit growth	8.47%
Gross profit growth (Q)	22.27%
Gross profit growth 3Y	6.06%
Gross profit growth 5Y	0.01%
Net income growth	11.46%
Net income growth (Q)	21.77%
Net income growth (QoQ)	6.25%
Net income growth 3Y	19.66%
Net income growth 5Y	-2.57%
Net income growth quarters	2
Net income growth years	2
OCF growth	-39.11%
OCF growth (Q)	-54.95%
OCF growth (QoQ)	245.69%
OCF growth 10Y	-1.65%
OCF growth 3Y	-28.45%
OCF growth 5Y	24.12%
Operating income growth	9.4%
Operating income growth (Q)	17.78%
Operating income growth 3Y	13.79%
Operating income growth 5Y	-1.64%
Revenue growth	10.38%
Revenue growth (Q)	29.52%
Revenue growth (QoQ)	8.59%
Revenue growth 10Y	3.48%
Revenue growth 3Y	-0.41%
Revenue growth 5Y	-2.94%
Revenue growth quarters	1
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-14.2M
Depreciation and amortization	$37.6M
EBIT	$921.8M
EBITDA	$959.5M
EPS	$5.57
FCF per share	$4.50
Financing cash flow	$-360.9M
Free cash flow	$519.8M
Free cash flow minus SBC	$421.7M
Gross profit	$1.5B
Income taxes	$152.3M
Investing cash flow	$-118.7M
Net borrowing	$685M
Net cash flow	$56.3M
Net income	$668.8M
Operating cash flow minus SBC	$435.9M
Operating income	$921.8M
Revenue	$18.2B
Stock-based compensation	$98.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$13.44
Debt / EBITDA	2.06
Debt / equity	1.36
Debt / FCF	4.14
Interest coverage	17.06
Long-term assets	$2.3B
Long-term liabilities	$1.7B
Net cash (debt)	$-2B
Net cash / market cap	-13.43%
Net debt / EBITDA	2.04
Net debt / equity	1.24
Net debt / FCF	3.77
Piotroski F-Score	4
Property, plant and equipment	$349.1M
Shareholders' equity	$1.6B
Tangible book value	$-330.9M
Tangible book value per share	$-2.82
Total assets	$6.4B
Total cash	$193.1M
Total debt	$2.2B
Total liabilities	$4.8B
WACC	8.51%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	3.14
Current assets	$4.1B
Current liabilities	$3.1B
Current ratio	1.34
Net working capital	$1.3B
Quick ratio	1.31
Working capital	$1B
Working capital turnover	16.97

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.12%
Dividend growth	1.61%
Dividend growth (10Y)	3.89%
Dividend growth (3Y)	1.08%
Dividend growth (5Y)	4.32%
Dividend growth years	28
Dividend payment date	2026-10-02
Dividend payment years	30
Dividend payout frequency	Quarterly
Dividend per share	$2.52
Dividend yield	1.98%
Ex-dividend date	2026-09-04
FCF payout ratio	55.98%
Last dividend	$0.63
Payout ratio	45.28%
Shareholder yield	3.11%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	88.89%
10Y return CAGR	9.04%
10Y total return	137.46%
150-day SMA	$166.13
15Y price change	81.28%
15Y return CAGR	6.47%
15Y total return	156.16%
1D price change	-11.41%
1M price change	-13.41%
1M total return	-13.41%
1W price change	-9.39%
1W total return	-9.39%
1Y price change	-1.31%
1Y return CAGR	0.2%
1Y total return	0.2%
20-day SMA	$141.04
200-day SMA	$170.00
20Y price change	197.87%
20Y return CAGR	7.9%
20Y total return	357.77%
3M price change	-26.99%
3M total return	-26.68%
3Y price change	56.74%
3Y return CAGR	18.8%
3Y total return	67.69%
50-day SMA	$146.00
50-day SMA vs 200-day SMA	50under200
52-week high	$210.33
52-week high date	2026-07-22
52-week low	$125.61
52-week low date	2026-10-28
5Y price change	30.45%
5Y return CAGR	7.88%
5Y total return	46.08%
6M price change	-32.4%
6M total return	-31.88%
All-time high	$210.33
All-time high date	2026-07-22
All-time low	$3.59
All-time low date	1998-10-08
Average true range (ATR)	$5.80
Average volume	2.3M
Beta (1Y)	0.91
Beta (2Y)	0.91
Beta (5Y)	0.95
Change from 52-week high	-39.52%
Change from 52-week low	1.27%
Change from all-time high	-39.44%
Change from all-time low	3,443.96%
Change from open	-4.73%
Day's gap	-7.01%
Dollar volume	$559.1M
High price	$136.09
Low price	$125.66
Monthly RSI	46.03
Open price	$133.52
Position in 52-week range	14.86%
Premarket change	-5.12%
Premarket close	$143.59
Premarket price	$136.24
Premarket volume	6.8K
Previous close	$143.59
Price vs 150-day SMA	-23.33%
Price vs 20-day SMA	-9.69%
Price vs 200-day SMA	-25.08%
Price vs 50-day SMA	-12.76%
Relative volume	1.92
RSI	33.15
Sharpe ratio	0.16
Sharpe ratio (3Y)	0.51
Sharpe ratio (5Y)	0.27
Sortino ratio	0.33
Sortino ratio (3Y)	0.9
Sortino ratio (5Y)	0.56
Volume	4.4M
Weekly RSI	36.89
YTD price change	-20.77%
YTD total return	-19.88%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	115M
Float percentage	99.63%
Shares change (QoQ)	-0.85%
Shares change (YoY)	-1.12%
Shares held by insiders	0.26%
Shares held by institutions	106.04%
Shares outstanding	115.5M
Short % of float	4.74%
Short % of shares	4.73%
Short ratio	4 days

Other indicators

Additional ticker metrics that do not fit the primary research groupings.

Metric	Value
Page views	204

Deeper analysis on CHRW

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Quote this valuation with its source: Fair value, Potential value and the price at analysis.

Frequently asked questions

About this CHRW report

What is the latest published CHRW stock rating?

C.H. Robinson Worldwide, Inc. is shown with Sell in the latest published report, analyzed 2026-10-12. The hub links directly to the full analysis surface where the dated rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CHRW analysis?

The full latest published report, analyzed 2026-10-12, lives at /stocks/CHRW/analysis. The bare ticker page summarizes that read and links to each analysis tab; earlier editions remain under /analysis/archive.

What fair value is used for CHRW?

The latest published report analyzed 2026-10-12 gives CHRW a fair value of USD 102 and a potential value of USD 126. These are dated research outputs, not live market prices; review the valuation assumptions, sensitivity analysis, and material risks before making a decision.

How often is the CHRW page updated?

The hub selects the latest published stock report regardless of age and displays its analysis date (2026-10-12). Separately sourced market data is labeled with its own recorded timestamp and is never inferred from the report.

SellCHRW · Fair value $102-26.4%

Read full analysis →

C.H. Robinson Worldwide, Inc. (CHRW)

Our latest published analysis: CHRW rated Sell

Price

Financial snapshot

Fair-value bridge

Latest news · CHRW

Valuation

Profitability

Balance sheet

Trading

Base and Bull scenarios

Sensitivity: Ke × terminal growth

Scorecard

Next earnings

Sector percentile context

All CHRW indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on CHRW

Frequently asked questions

Rating history

Category	Score	Reading
Valuation	1.5
Management	7.5
Balance Sheet	6.0
Profitability	7.0
Revenue Growth	7.5
Risk Assessment	6.0
Competitive Moat	6.5
Earnings Quality	9.0
Capital Efficiency	7.5